Variants in GSTZ1 Gene Underlying Maleylacetoacetate Isomerase Deficiency: Characterization of Two New Individuals and Literature Review
Genes · 2025
DOI: 10.3390/genes16091009 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, 2025. Verfasst von Ferdinando Barretta und 13 weiteren Autor:innen. Beteiligte Einrichtung: CEINGE Biotecnologie Avanzate-Franco Salvatore s.c.ar.l., 80131 Naples, Italy. Hauptthemen laut MEDLINE: Tyrosinemias. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Elevated succinylacetone (SA) is the hallmark of tyrosinemia type 1, which requires immediate treatment. Mild SA elevation has also been recently reported in maleylacetoacetate isomerase deficiency (MAAID).
Methods
We report on two cases of MAAID, review clinical features of MAAID and discuss its management.
Results
Both cases displayed elevated SA and normal Tyrosine levels at newborn screening. Case 1 showed intermittent SA elevation; Nitisinone and dietary treatment were started, then discontinued after the identification of two variants in the GSTZ1 gene and the definitive diagnosis of MAAID. Case 2, showing no SA elevation at the confirmatory tests and two variants in the GSTZ1 gene, did not start treatment. mRNA analysis confirmed the pathogenicity of the c.68-12G>A variant, found in both patients.
Discussion
MAAID should be considered in newborns showing elevated SA and no variants in the FAH gene. Our study reports for the first time the course of SA in a patient affected by MAAID. Furthermore, it expands the molecular epidemiology of this rare disease, also investigating the pathogenicity of a novel splicing mutation. Although our data argue against medical treatment in MAAID, longer follow-up data are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CEINGE Biotecnologie Avanzate-Franco Salvatore s.c.ar.l., 80131 Naples, Italy.
- Department of Advanced Biomedical Science, University of Naples "Federico II", 80131 Naples, Italy.
- Department of Translational Medical Science, Section of Paediatrics, University of Naples "Federico II", 80131 Naples, Italy.
- Department of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", 80131 Naples, Italy.
- Department of Integrated Maternal-Fetal Care, "Federico II" University Hospital, 80131 Naples, Italy.
ORCID-Profile: Alessandra Verde, Cristina Mazzaccara, Giulia Frisso, Alessandro Rossi
Zitieren
APA
Barretta, F., Uomo, F., Verde, A., Fisco, M., Gallo, G., Albano, L., Crisci, D., Mazzaccara, C., Strisciuglio, P., Ruoppolo, M., Fecarotta, S., Parenti, G., Frisso, G., & Rossi, A. (2025). Variants in GSTZ1 Gene Underlying Maleylacetoacetate Isomerase Deficiency: Characterization of Two New Individuals and Literature Review. Genes. https://doi.org/10.3390/genes16091009
Vancouver
Barretta F, Uomo F, Verde A, Fisco M, Gallo G, Albano L, et al. Variants in GSTZ1 Gene Underlying Maleylacetoacetate Isomerase Deficiency: Characterization of Two New Individuals and Literature Review. Genes. 2025. doi:10.3390/genes16091009
BibTeX
@article{Barretta2025,
author = {Barretta, Ferdinando and Uomo, Fabiana and Verde, Alessandra and Fisco, Mariagrazia and Gallo, Giovanna and Albano, Lucia and Crisci, Daniela and Mazzaccara, Cristina and Strisciuglio, Pietro and Ruoppolo, Margherita and Fecarotta, Simona and Parenti, Giancarlo and Frisso, Giulia and Rossi, Alessandro},
title = {Variants in GSTZ1 Gene Underlying Maleylacetoacetate Isomerase Deficiency: Characterization of Two New Individuals and Literature Review},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16091009}
}
EUVIMED